Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19874804 | 0.86 | TSHR (0.53) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL19874821 | 0.86 | TSHR (0.53) | TSHRLMNATHRBDNM1ALDH1A1 | |
| SCHEMBL8966617 | 0.75 | — | — | |
| SCHEMBL10899969 | 0.72 | ANPEP (0.53) | ANPEPTSHRLMNATHRBDNM1 | |
| SCHEMBL1237 | 0.72 | ANPEP (0.53) | ANPEPTSHRLMNATHRBDNM1 | |
| SCHEMBL952691 | 0.69 | ANPEP (0.50) | ANPEPTSHRLMNATHRBDNM1 | |
| SCHEMBL792029 | 0.69 | — | — | |
| SCHEMBL9814415 | 0.69 | ANPEP (0.50) | ANPEPTSHRLMNATHRBDNM1 | |
| SCHEMBL3887127 | 0.69 | ANPEP (0.50) | ANPEPTSHRLMNATHRBDNM1 | |
| SCHEMBL51210 | 0.69 | ANPEP (0.50) | ANPEPTSHRLMNATHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116374949-A | Power system for generating at least one of electrical energy and thermal energy | 辉光能源公司 | 2023-07-04 | — | — | CN | disclosed |
| EP-4181241-A1 | H20 - BASED ELECTROCHEMICAL HYDROGEN - CATALYST POWER SYSTEM | Brilliant Light Power, Inc. (US) | 2023-05-17 | — | — | EP | disclosed |
| EP-3996109-A2 | THERMOPHOTOVOLTAIC ELECTRICAL POWER GENERATOR | Brilliant Light Power, Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
| US-20210313606-A1 | H2O-BASED ELECTROCHEMICAL HYDROGEN-CATALYST POWER SYSTEM | BRILLIANT LIGHT POWER, INC. (US) | 2021-10-07 | — | — | US | disclosed |
| US-20200403555-A1 | THERMOPHOTOVOLTAIC ELECTRICAL POWER GENERATOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-12-24 | — | — | US | disclosed |
| EP-2548257-B1 | ELECTROCHEMICAL HYDROGEN-CATALYST POWER SYSTEM | BLACKLIGHT POWER INC (US) | 2019-09-11 | — | — | EP | disclosed |
| US-20180159459-A1 | THERMOPHOTOVOLTAIC ELECTRICAL POWER GENERATOR | BRILLIANT LIGHT POWER, INC. | 2018-06-07 | — | — | US | disclosed |
| US-20140072836-A1 | H2O-BASED ELECTROCHEMICAL HYDROGEN-CATALYST POWER SYSTEM | BLACKLIGHT POWER, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-20130084474-A1 | ELECTROCHEMICAL HYDROGEN-CATALYST POWER SYSTEM | BRILLIANT LIGHT POWER, INC. | 2013-04-04 | — | — | US | disclosed |
| US-20090256111-A1 | DIALKYLBORANE AMINE COMPLEXES | BASF SE PATENTS, TRADEMARKS AND LICENSES (DE) | 2009-10-15 | — | — | US | disclosed |
| WO-1999006414-A1 | COMPOUNDS CONTAINING BORON AND ALUMINIUM | TARGOR GMBH (DE) | 1999-02-11 | — | — | WO | disclosed |
| EP-0519496-B1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | TONEN CORP (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0404503-B1 | Boron-containing, silicon nitride-based ceramic shaped body production process | TONEN CORP (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0389084-B1 | Process for producing a polyborosilazane | TONEN CORP (JP) | 1995-09-20 | — | — | EP | disclosed |
| US-5292830-A | Silane, silazane, boron block crosslinked copolymers | TONEN CORPORATION (JP) | 1994-03-08 | — | — | US | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5128286-A | BORON-CONTAINING, SILICON NITRIDE-BASED CERAMIC SHAPED BODY | TONEN CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5030744-A | Polyborosilazane and process for producing same | TONEN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090256111-A1 | DIALKYLBORANE AMINE COMPLEXES | AOC1, DDC, AOC2 | ANPEP 2851/4885TSHR 2890/4885LMNA 3535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.